The Valley Desk

ReviewThe Lancet. OncologyPublished

Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS)

12 of 36 authors shown in byline order.

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Review
Venue
The Lancet. Oncology
Published
Subject terms
Humans; Neuroendocrine Tumors; Receptors, Somatostatin; Radiopharmaceuticals; Positron-Emission Tomography; Treatment Outcome; Delphi Technique; Europe
PubMed ID
42398521
Added to directory
Source checked

Report a correction or request removal